Related references
Note: Only part of the references are listed.Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis
Angelique L. W. M. M. Rops et al.
KIDNEY INTERNATIONAL (2014)
The role of heparanase and the endothelial glycocalyx in the development of proteinuria
Marjolein Garsen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Reduced Sulfation of Chondroitin Sulfate but Not Heparan Sulfate in Kidneys of Diabetic db/db Mice
Trine M. Reine et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
Sulodexide Decreases Albuminuria and Regulates Matrix Protein Accumulation in C57BL/6 Mice with Streptozotocin-Induced Type I Diabetic Nephropathy
Susan Yung et al.
PLOS ONE (2013)
Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin
J. Han et al.
VASCULAR PHARMACOLOGY (2013)
Discounting the Efficacy of Sulodexide in Diabetic Nephropathy Is Premature
Giovanni Gambaro
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
Natali Gil et al.
DIABETES (2012)
Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
David K. Packham et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
Valentina Masola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy
E. Jennifer Weil et al.
KIDNEY INTERNATIONAL (2012)
Urinary heparanase activity in patients with Type 1 and Type 2 diabetes
Angelique L. W. M. M. Rops et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Significance of Heparanase in Cancer and Inflammation
Israel Vlodavsky et al.
CANCER MICROENVIRONMENT (2012)
Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
Edmund J. Lewis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats
Celia M. C. Strunz et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Diabetes results in structural alteration of chondroitin sulfate/dermatan sulfate in the rat kidney: effects on the binding to extracellular matrix components
Darukeshwara Joladarashi et al.
GLYCOBIOLOGY (2011)
Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations
Magdalena Bacilieri et al.
GLYCOBIOLOGY (2011)
Heparanase Levels Are Elevated in the Urine and Plasma of Type 2 Diabetes Patients and Associate with Blood Glucose Levels
Itay Shafat et al.
PLOS ONE (2011)
High glucose causes dysfunction of the human glomerular endothelial glycocalyx
A. Singh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Diabetic kidney disease: act now or pay later
R. C. Atkins et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Fucosylated chondroitin sulfate attenuates renal fibrosis in animals submitted to unilateral ureteral obstruction: a P-selectin-mediated event?
Nelson M. Melo-Filho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane
Seth Goldberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species
Mabel J. van den Hoven et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria
M. J. van den Hoven et al.
KIDNEY INTERNATIONAL (2008)
Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria
Shoujun Chen et al.
KIDNEY INTERNATIONAL (2008)
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
J. A. Jefferson et al.
KIDNEY INTERNATIONAL (2008)
Properties of the glomerular barrier and mechanisms of proteinuria
Borje Haraldsson et al.
PHYSIOLOGICAL REVIEWS (2008)
Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy
T. J. M. Wijnhoven et al.
DIABETOLOGIA (2008)
Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity
Scott J. Harvey et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber - Effect on tumor metastasis and neutrophil recruitment
Lubor Borsig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria
Tessa J. M. Wijnhoven et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Increased expression of heparanase in overt diabetic nephropathy
M. J. van den Hoven et al.
KIDNEY INTERNATIONAL (2006)
Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome
A. Bjornson Granqvist et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice
M. Jeansson et al.
DIABETOLOGIA (2006)
Effects of low molecular weight heparin in obstructed kidneys:: decrease of collagen, fibronectin and TGF-β, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration
IMD Pecly et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes
Jing Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool
EP Girardin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells - A potential role in the pathogenesis of proteinuria in diabetic patients
JB Maxhimer et al.
DIABETES (2005)
From the periphery of the glomerular capillary wall toward the center of disease - Podocyte injury comes of age in diabetic nephropathy
G Wolf et al.
DIABETES (2005)
From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines
BF Schrijvers et al.
ENDOCRINE REVIEWS (2004)
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type I and type 2 diabetic patients:: The Di.NAS randomized trial
G Gambaro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Cloning and characterization of the human heparanase-1 (HPR1) gene promoter -: Role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity
P Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-β1 gene activation
C Weigert et al.
KIDNEY INTERNATIONAL (2001)
A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes
ASB Edge et al.
DIABETOLOGIA (2000)
Share Paper
